|
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic workflows.
|
 |
|
The rare disease framework has had a turbulent past few years, with the FDA looking to create regulatory stability.
|
|
|
Gan & Lee will receive a $5m upfront payment plus up to $76.1m in milestone payments.
|
|
|
Everest Medicines will pay $250m in three instalments: $150m at closing, two $50m payments in 2028, 2029.
|
|
|
This funding will boost the US’s antibiotic manufacturing capacity, while helping to curb the threat of antimicrobial resistance (AMR) across America.
|
|
